⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL293574 | 0.85 | — | — | |
| SCHEMBL14590766 | 0.83 | HIF1A (0.65) | — | |
| SCHEMBL8107 | 0.83 | KDM4E (0.71) | — | |
| SCHEMBL404097 | 0.82 | — | — | |
| SCHEMBL204637 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL9636118 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL15743759 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL19606333 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL8810970 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL29951519 | 0.81 | KDM4E (0.70) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190285632-A1 | METABALOMICS AND VIRAL DIAGNOSTICS SUITE | EXCISION BIOTHERAPEUTICS, INC. (US) | 2019-09-19 | — | — | US | claimed |
| EP-3510148-A1 | HIV CLINICAL PLAN | Excision Biotherapeutics, Inc. (US) | 2019-07-17 | — | — | EP | claimed |
| US-20190194652-A1 | HIV CLINICAL PLAN | EXCISION BIOTHERAPEUTICS, INC. (US) | 2019-06-27 | — | — | US | claimed |
| CN-109689866-A | HIV clinical program | 切除生物治疗公司 | 2019-04-26 | — | — | CN | claimed |
| EP-3465213-A1 | METABALOMICS AND VIRAL DIAGNOSTICS SUITE | Excision Biotherapeutics, Inc. (US) | 2019-04-10 | — | — | EP | claimed |
| CN-109154610-A | Metabolomics and Viral Diagnostic Kits | 切除生物治疗公司 | 2019-01-04 | — | — | CN | claimed |
| US-20180340202-A1 | Method for Rapid High Volume Production of Synthetic Vaccines | POSTREL RICHARD (US) | 2018-11-29 | — | — | US | claimed |
| WO-2018049372-A1 | HIV CLINICAL PLAN | EXCISION BIOTHERAPEUTICS INC (US) | 2018-03-15 | — | — | WO | claimed |
| WO-2017205460-A1 | METABALOMICS AND VIRAL DIAGNOSTICS SUITE | EXCISION BIOTHERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | claimed |
| EP-2185713-A2 | PROCESS FOR PREPARING CHIRAL COMPOUNDS | Pfizer Products Inc. (US) | 2010-05-19 | — | — | EP | claimed |
| WO-2009019561-A2 | PROCESS FOR PREPARING CHIRAL COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2009-02-12 | — | — | WO | claimed |
| EP-1893767-A1 | PROCESS FOR PRODUCING ATORVASTATIN, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND INTERMEDIATES THEREOF | Pfizer, Inc. (US) | 2008-03-05 | — | — | EP | claimed |
| WO-2006134482-A1 | PROCESS FOR PRODUCING ATORVASTATIN, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND INTERMEDIATES THEREOF | PFIZER INC. (US) | 2006-12-21 | — | — | WO | claimed |
| US-4226870-A | ANTIBIOTICS, BACTERICIDES | MERCK & CO., INC. (US) | 1980-10-07 | — | — | US | claimed |
| EP-0001265-A1 | O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | claimed |
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-4729603-A2 | METABOLOMIC CHARACTERIZATION OF MICROORGANISMS | Lewis, Ian Andrew (CA) | 2026-04-22 | — | — | EP | disclosed |
| EP-0382185-A2 | Carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4062947-A | Di-N-alkylaminoglycosides, methods for their manufacture and novel intermediates useful therein, method for their use as antibacterial agents and pharmaceutical compositions useful therefor | SCHERING CORPORATION (US) | 1977-12-13 | — | — | US | disclosed |
| US-4002742-A | 1-N-alkyl-4,6-di-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, methods for their use as antibacterial agents, and compositions useful therefor | SCHERING CORPORATION (US) | 1977-01-11 | — | — | US | disclosed |